Rheumatoid cachexia: a clinical perspective.

Area of Science:

• Rheumatology
• Metabolic Disorders
• Body Composition Analysis

Background:

• Rheumatoid cachexia is a prevalent yet under-recognized complication in rheumatoid arthritis (RA).
• Cachexia in RA often presents as loss of lean body mass, frequently obscured by fat gain, leading to normal or elevated Body Mass Index (BMI) in many patients.
• Despite normal BMI, significant muscle loss in RA is linked to adverse clinical outcomes, including increased morbidity and mortality.

Purpose of the Study:

• To highlight the clinical significance of rheumatoid cachexia.
• To discuss the challenges and advancements in assessing body composition in RA patients.
• To explore potential therapeutic strategies for managing rheumatoid cachexia.

Main Methods:

• Review of existing literature on rheumatoid cachexia and body composition in RA.
• Discussion of diagnostic techniques including Dual-energy X-ray Absorptiometry (DXA) and emerging methods like whole-body Magnetic Resonance Imaging (MRI).
• Analysis of the relationship between body composition parameters and clinical outcomes in RA.

Main Results:

• A high percentage (85%+) of RA patients exhibit normal BMI due to 'cachectic obesity', masking underlying muscle loss.
• Reduced muscle mass, even with normal BMI, correlates with poorer clinical outcomes in RA.
• Higher BMI, including the obese range, has been associated with reduced joint damage and mortality in RA patients.

Conclusions:

• Accurate assessment of body composition is crucial for understanding RA prognosis.
• While diet alone is ineffective, progressive resistance training and anti-tumor necrosis factor (anti-TNF) therapies demonstrate potential in managing rheumatoid cachexia.
• Further research utilizing advanced imaging techniques like MRI is needed to better define body composition-outcome relationships in RA.